Loading…

The Validity and Reliability of Screening Measures for Depression and Anxiety Disorders in Inflammatory Bowel Disease

Abstract Background We evaluated the validity and reliability of multiple symptom scales for depression and anxiety for persons with inflammatory bowel disease (IBD). Methods IBD participants in a cohort study completed a Structured Clinical Interview for DSM-IV-TR Axis I Disorders (SCID) and comple...

Full description

Saved in:
Bibliographic Details
Published in:Inflammatory bowel diseases 2018-08, Vol.24 (9), p.1867-1875
Main Authors: Bernstein, Charles N, Zhang, Lixia, Lix, Lisa M, Graff, Lesley A, Walker, John R, Fisk, John D, Patten, Scott B, Hitchon, Carol A, Bolton, James M, Sareen, Jitender, El-Gabalawy, Renée, Marriott, James, Marrie, Ruth Ann
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c408t-522e7596382f0e26dc05ef7e0e91ba2f6bfb50251e5b2a6b9fba8e8be68bafb3
cites cdi_FETCH-LOGICAL-c408t-522e7596382f0e26dc05ef7e0e91ba2f6bfb50251e5b2a6b9fba8e8be68bafb3
container_end_page 1875
container_issue 9
container_start_page 1867
container_title Inflammatory bowel diseases
container_volume 24
creator Bernstein, Charles N
Zhang, Lixia
Lix, Lisa M
Graff, Lesley A
Walker, John R
Fisk, John D
Patten, Scott B
Hitchon, Carol A
Bolton, James M
Sareen, Jitender
El-Gabalawy, Renée
Marriott, James
Marrie, Ruth Ann
description Abstract Background We evaluated the validity and reliability of multiple symptom scales for depression and anxiety for persons with inflammatory bowel disease (IBD). Methods IBD participants in a cohort study completed a Structured Clinical Interview for DSM-IV-TR Axis I Disorders (SCID) and completed the Patient Health Questionnaire (PHQ-9), Hospital Anxiety and Depression Scale (HADS), Kessler-6 Distress Scale, PROMIS Emotional Distress Depression Short-Form 8a (PROMIS Depression) and Anxiety Short-Form 8a (PROMIS Anxiety), Generalized Anxiety Disorder 7-item Scale, and Overall Anxiety and Severity Impairment Scale. We computed sensitivity, specificity, and positive and negative predictive values for the screening measures with the SCID diagnoses as the reference standard, conducted receiver operating curve (ROC) analysis, and assessed internal consistency and test-retest reliability. Results Of 242 participants, the SCID classified 8.7% as having major depression and 17.8% as having anxiety disorders. Among the depression scales, the PHQ-9 had the highest sensitivity (95%). Specificity was generally higher than sensitivity and was highest for the HADS-D (cut-point of 11; 97%). The area under the ROC curve (AUC) did not differ significantly among depression scales. Among the anxiety scales, sensitivity was highest for the PROMIS (79%). Specificity ranged from 82% to 88% for all tools except the HADS-A (cut-point of 8; 65%). The AUC did not differ between depression and anxiety tools. Conclusions Overall, the symptom scales for depression and anxiety were similar in their psychometric properties. The anxiety scales did not perform as well as the depression scales. Alternate cut-points may be more relevant when these scales are used in an IBD sample.
doi_str_mv 10.1093/ibd/izy068
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6124738</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/ibd/izy068</oup_id><sourcerecordid>2027586563</sourcerecordid><originalsourceid>FETCH-LOGICAL-c408t-522e7596382f0e26dc05ef7e0e91ba2f6bfb50251e5b2a6b9fba8e8be68bafb3</originalsourceid><addsrcrecordid>eNp9kU1vFSEUhonR2Frd-AMMG5PGZCwwAwMbk9r60aTGRG_cEpg5tBgGrjDT9vrr5Xrbpm4MCw45z3kgvAi9pOQtJao98nY88r83RMhHaJ_yVjSd7LrHtSa9bIhScg89K-UnIawu9RTtMSWEVJTuo2V1CfiHCX708wabOOJvELyxPmzPyeHvQwaIPl7gL2DKkqFglzI-hXUti0_x79BxvPFQB059SXmEXLCP-Cy6YKbJzClv8Pt0DWHbrxZ4jp44Ewq8uN0P0Orjh9XJ5-b866ezk-PzZuiInBvOGPRciVYyR4CJcSAcXA8EFLWGOWGd5YRxCtwyI6xy1kiQFoS0xtn2AL3badeLnWAcIM7ZBL3OfjJ5o5Px-t9O9Jf6Il1pQVnXt7IKDm8FOf1aoMx68mWAEEyEtBRd_7PnUnDRVvTNDh1yKiWDu7-GEr2NSdeY9C6mCr96-LB79C6XCrzeAWlZ_0_0B8T8n3Q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2027586563</pqid></control><display><type>article</type><title>The Validity and Reliability of Screening Measures for Depression and Anxiety Disorders in Inflammatory Bowel Disease</title><source>Oxford Journals Online</source><creator>Bernstein, Charles N ; Zhang, Lixia ; Lix, Lisa M ; Graff, Lesley A ; Walker, John R ; Fisk, John D ; Patten, Scott B ; Hitchon, Carol A ; Bolton, James M ; Sareen, Jitender ; El-Gabalawy, Renée ; Marriott, James ; Marrie, Ruth Ann</creator><creatorcontrib>Bernstein, Charles N ; Zhang, Lixia ; Lix, Lisa M ; Graff, Lesley A ; Walker, John R ; Fisk, John D ; Patten, Scott B ; Hitchon, Carol A ; Bolton, James M ; Sareen, Jitender ; El-Gabalawy, Renée ; Marriott, James ; Marrie, Ruth Ann ; CIHR Team in Defining the Burden and Managing the Effects of Immune-mediated Inflammatory Disease ; CIHR Team in Defining the Burden and Managing the Effects of Immune-mediated Inflammatory Disease</creatorcontrib><description>Abstract Background We evaluated the validity and reliability of multiple symptom scales for depression and anxiety for persons with inflammatory bowel disease (IBD). Methods IBD participants in a cohort study completed a Structured Clinical Interview for DSM-IV-TR Axis I Disorders (SCID) and completed the Patient Health Questionnaire (PHQ-9), Hospital Anxiety and Depression Scale (HADS), Kessler-6 Distress Scale, PROMIS Emotional Distress Depression Short-Form 8a (PROMIS Depression) and Anxiety Short-Form 8a (PROMIS Anxiety), Generalized Anxiety Disorder 7-item Scale, and Overall Anxiety and Severity Impairment Scale. We computed sensitivity, specificity, and positive and negative predictive values for the screening measures with the SCID diagnoses as the reference standard, conducted receiver operating curve (ROC) analysis, and assessed internal consistency and test-retest reliability. Results Of 242 participants, the SCID classified 8.7% as having major depression and 17.8% as having anxiety disorders. Among the depression scales, the PHQ-9 had the highest sensitivity (95%). Specificity was generally higher than sensitivity and was highest for the HADS-D (cut-point of 11; 97%). The area under the ROC curve (AUC) did not differ significantly among depression scales. Among the anxiety scales, sensitivity was highest for the PROMIS (79%). Specificity ranged from 82% to 88% for all tools except the HADS-A (cut-point of 8; 65%). The AUC did not differ between depression and anxiety tools. Conclusions Overall, the symptom scales for depression and anxiety were similar in their psychometric properties. The anxiety scales did not perform as well as the depression scales. Alternate cut-points may be more relevant when these scales are used in an IBD sample.</description><identifier>ISSN: 1078-0998</identifier><identifier>EISSN: 1536-4844</identifier><identifier>DOI: 10.1093/ibd/izy068</identifier><identifier>PMID: 29668911</identifier><language>eng</language><publisher>US: Oxford University Press</publisher><subject>Adult ; Anxiety Disorders - diagnosis ; Anxiety Disorders - etiology ; Cohort Studies ; Colitis, Ulcerative - psychology ; Crohn Disease - psychology ; Depressive Disorder - diagnosis ; Depressive Disorder - etiology ; Female ; Humans ; IBD Live ; Male ; Middle Aged ; Patient Health Questionnaire - standards ; Predictive Value of Tests ; Psychiatric Status Rating Scales - standards ; Psychometrics ; Reproducibility of Results ; ROC Curve ; Sensitivity and Specificity</subject><ispartof>Inflammatory bowel diseases, 2018-08, Vol.24 (9), p.1867-1875</ispartof><rights>2018 Crohn's &amp; Colitis Foundation. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. 2018</rights><rights>2018 Crohn’s &amp; Colitis Foundation. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</rights><rights>2018 Crohn’s &amp; Colitis Foundation. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c408t-522e7596382f0e26dc05ef7e0e91ba2f6bfb50251e5b2a6b9fba8e8be68bafb3</citedby><cites>FETCH-LOGICAL-c408t-522e7596382f0e26dc05ef7e0e91ba2f6bfb50251e5b2a6b9fba8e8be68bafb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29668911$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bernstein, Charles N</creatorcontrib><creatorcontrib>Zhang, Lixia</creatorcontrib><creatorcontrib>Lix, Lisa M</creatorcontrib><creatorcontrib>Graff, Lesley A</creatorcontrib><creatorcontrib>Walker, John R</creatorcontrib><creatorcontrib>Fisk, John D</creatorcontrib><creatorcontrib>Patten, Scott B</creatorcontrib><creatorcontrib>Hitchon, Carol A</creatorcontrib><creatorcontrib>Bolton, James M</creatorcontrib><creatorcontrib>Sareen, Jitender</creatorcontrib><creatorcontrib>El-Gabalawy, Renée</creatorcontrib><creatorcontrib>Marriott, James</creatorcontrib><creatorcontrib>Marrie, Ruth Ann</creatorcontrib><creatorcontrib>CIHR Team in Defining the Burden and Managing the Effects of Immune-mediated Inflammatory Disease</creatorcontrib><creatorcontrib>CIHR Team in Defining the Burden and Managing the Effects of Immune-mediated Inflammatory Disease</creatorcontrib><title>The Validity and Reliability of Screening Measures for Depression and Anxiety Disorders in Inflammatory Bowel Disease</title><title>Inflammatory bowel diseases</title><addtitle>Inflamm Bowel Dis</addtitle><description>Abstract Background We evaluated the validity and reliability of multiple symptom scales for depression and anxiety for persons with inflammatory bowel disease (IBD). Methods IBD participants in a cohort study completed a Structured Clinical Interview for DSM-IV-TR Axis I Disorders (SCID) and completed the Patient Health Questionnaire (PHQ-9), Hospital Anxiety and Depression Scale (HADS), Kessler-6 Distress Scale, PROMIS Emotional Distress Depression Short-Form 8a (PROMIS Depression) and Anxiety Short-Form 8a (PROMIS Anxiety), Generalized Anxiety Disorder 7-item Scale, and Overall Anxiety and Severity Impairment Scale. We computed sensitivity, specificity, and positive and negative predictive values for the screening measures with the SCID diagnoses as the reference standard, conducted receiver operating curve (ROC) analysis, and assessed internal consistency and test-retest reliability. Results Of 242 participants, the SCID classified 8.7% as having major depression and 17.8% as having anxiety disorders. Among the depression scales, the PHQ-9 had the highest sensitivity (95%). Specificity was generally higher than sensitivity and was highest for the HADS-D (cut-point of 11; 97%). The area under the ROC curve (AUC) did not differ significantly among depression scales. Among the anxiety scales, sensitivity was highest for the PROMIS (79%). Specificity ranged from 82% to 88% for all tools except the HADS-A (cut-point of 8; 65%). The AUC did not differ between depression and anxiety tools. Conclusions Overall, the symptom scales for depression and anxiety were similar in their psychometric properties. The anxiety scales did not perform as well as the depression scales. Alternate cut-points may be more relevant when these scales are used in an IBD sample.</description><subject>Adult</subject><subject>Anxiety Disorders - diagnosis</subject><subject>Anxiety Disorders - etiology</subject><subject>Cohort Studies</subject><subject>Colitis, Ulcerative - psychology</subject><subject>Crohn Disease - psychology</subject><subject>Depressive Disorder - diagnosis</subject><subject>Depressive Disorder - etiology</subject><subject>Female</subject><subject>Humans</subject><subject>IBD Live</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Patient Health Questionnaire - standards</subject><subject>Predictive Value of Tests</subject><subject>Psychiatric Status Rating Scales - standards</subject><subject>Psychometrics</subject><subject>Reproducibility of Results</subject><subject>ROC Curve</subject><subject>Sensitivity and Specificity</subject><issn>1078-0998</issn><issn>1536-4844</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp9kU1vFSEUhonR2Frd-AMMG5PGZCwwAwMbk9r60aTGRG_cEpg5tBgGrjDT9vrr5Xrbpm4MCw45z3kgvAi9pOQtJao98nY88r83RMhHaJ_yVjSd7LrHtSa9bIhScg89K-UnIawu9RTtMSWEVJTuo2V1CfiHCX708wabOOJvELyxPmzPyeHvQwaIPl7gL2DKkqFglzI-hXUti0_x79BxvPFQB059SXmEXLCP-Cy6YKbJzClv8Pt0DWHbrxZ4jp44Ewq8uN0P0Orjh9XJ5-b866ezk-PzZuiInBvOGPRciVYyR4CJcSAcXA8EFLWGOWGd5YRxCtwyI6xy1kiQFoS0xtn2AL3badeLnWAcIM7ZBL3OfjJ5o5Px-t9O9Jf6Il1pQVnXt7IKDm8FOf1aoMx68mWAEEyEtBRd_7PnUnDRVvTNDh1yKiWDu7-GEr2NSdeY9C6mCr96-LB79C6XCrzeAWlZ_0_0B8T8n3Q</recordid><startdate>20180816</startdate><enddate>20180816</enddate><creator>Bernstein, Charles N</creator><creator>Zhang, Lixia</creator><creator>Lix, Lisa M</creator><creator>Graff, Lesley A</creator><creator>Walker, John R</creator><creator>Fisk, John D</creator><creator>Patten, Scott B</creator><creator>Hitchon, Carol A</creator><creator>Bolton, James M</creator><creator>Sareen, Jitender</creator><creator>El-Gabalawy, Renée</creator><creator>Marriott, James</creator><creator>Marrie, Ruth Ann</creator><general>Oxford University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20180816</creationdate><title>The Validity and Reliability of Screening Measures for Depression and Anxiety Disorders in Inflammatory Bowel Disease</title><author>Bernstein, Charles N ; Zhang, Lixia ; Lix, Lisa M ; Graff, Lesley A ; Walker, John R ; Fisk, John D ; Patten, Scott B ; Hitchon, Carol A ; Bolton, James M ; Sareen, Jitender ; El-Gabalawy, Renée ; Marriott, James ; Marrie, Ruth Ann</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c408t-522e7596382f0e26dc05ef7e0e91ba2f6bfb50251e5b2a6b9fba8e8be68bafb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Adult</topic><topic>Anxiety Disorders - diagnosis</topic><topic>Anxiety Disorders - etiology</topic><topic>Cohort Studies</topic><topic>Colitis, Ulcerative - psychology</topic><topic>Crohn Disease - psychology</topic><topic>Depressive Disorder - diagnosis</topic><topic>Depressive Disorder - etiology</topic><topic>Female</topic><topic>Humans</topic><topic>IBD Live</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Patient Health Questionnaire - standards</topic><topic>Predictive Value of Tests</topic><topic>Psychiatric Status Rating Scales - standards</topic><topic>Psychometrics</topic><topic>Reproducibility of Results</topic><topic>ROC Curve</topic><topic>Sensitivity and Specificity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bernstein, Charles N</creatorcontrib><creatorcontrib>Zhang, Lixia</creatorcontrib><creatorcontrib>Lix, Lisa M</creatorcontrib><creatorcontrib>Graff, Lesley A</creatorcontrib><creatorcontrib>Walker, John R</creatorcontrib><creatorcontrib>Fisk, John D</creatorcontrib><creatorcontrib>Patten, Scott B</creatorcontrib><creatorcontrib>Hitchon, Carol A</creatorcontrib><creatorcontrib>Bolton, James M</creatorcontrib><creatorcontrib>Sareen, Jitender</creatorcontrib><creatorcontrib>El-Gabalawy, Renée</creatorcontrib><creatorcontrib>Marriott, James</creatorcontrib><creatorcontrib>Marrie, Ruth Ann</creatorcontrib><creatorcontrib>CIHR Team in Defining the Burden and Managing the Effects of Immune-mediated Inflammatory Disease</creatorcontrib><creatorcontrib>CIHR Team in Defining the Burden and Managing the Effects of Immune-mediated Inflammatory Disease</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Inflammatory bowel diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bernstein, Charles N</au><au>Zhang, Lixia</au><au>Lix, Lisa M</au><au>Graff, Lesley A</au><au>Walker, John R</au><au>Fisk, John D</au><au>Patten, Scott B</au><au>Hitchon, Carol A</au><au>Bolton, James M</au><au>Sareen, Jitender</au><au>El-Gabalawy, Renée</au><au>Marriott, James</au><au>Marrie, Ruth Ann</au><aucorp>CIHR Team in Defining the Burden and Managing the Effects of Immune-mediated Inflammatory Disease</aucorp><aucorp>CIHR Team in Defining the Burden and Managing the Effects of Immune-mediated Inflammatory Disease</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Validity and Reliability of Screening Measures for Depression and Anxiety Disorders in Inflammatory Bowel Disease</atitle><jtitle>Inflammatory bowel diseases</jtitle><addtitle>Inflamm Bowel Dis</addtitle><date>2018-08-16</date><risdate>2018</risdate><volume>24</volume><issue>9</issue><spage>1867</spage><epage>1875</epage><pages>1867-1875</pages><issn>1078-0998</issn><eissn>1536-4844</eissn><abstract>Abstract Background We evaluated the validity and reliability of multiple symptom scales for depression and anxiety for persons with inflammatory bowel disease (IBD). Methods IBD participants in a cohort study completed a Structured Clinical Interview for DSM-IV-TR Axis I Disorders (SCID) and completed the Patient Health Questionnaire (PHQ-9), Hospital Anxiety and Depression Scale (HADS), Kessler-6 Distress Scale, PROMIS Emotional Distress Depression Short-Form 8a (PROMIS Depression) and Anxiety Short-Form 8a (PROMIS Anxiety), Generalized Anxiety Disorder 7-item Scale, and Overall Anxiety and Severity Impairment Scale. We computed sensitivity, specificity, and positive and negative predictive values for the screening measures with the SCID diagnoses as the reference standard, conducted receiver operating curve (ROC) analysis, and assessed internal consistency and test-retest reliability. Results Of 242 participants, the SCID classified 8.7% as having major depression and 17.8% as having anxiety disorders. Among the depression scales, the PHQ-9 had the highest sensitivity (95%). Specificity was generally higher than sensitivity and was highest for the HADS-D (cut-point of 11; 97%). The area under the ROC curve (AUC) did not differ significantly among depression scales. Among the anxiety scales, sensitivity was highest for the PROMIS (79%). Specificity ranged from 82% to 88% for all tools except the HADS-A (cut-point of 8; 65%). The AUC did not differ between depression and anxiety tools. Conclusions Overall, the symptom scales for depression and anxiety were similar in their psychometric properties. The anxiety scales did not perform as well as the depression scales. Alternate cut-points may be more relevant when these scales are used in an IBD sample.</abstract><cop>US</cop><pub>Oxford University Press</pub><pmid>29668911</pmid><doi>10.1093/ibd/izy068</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1078-0998
ispartof Inflammatory bowel diseases, 2018-08, Vol.24 (9), p.1867-1875
issn 1078-0998
1536-4844
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6124738
source Oxford Journals Online
subjects Adult
Anxiety Disorders - diagnosis
Anxiety Disorders - etiology
Cohort Studies
Colitis, Ulcerative - psychology
Crohn Disease - psychology
Depressive Disorder - diagnosis
Depressive Disorder - etiology
Female
Humans
IBD Live
Male
Middle Aged
Patient Health Questionnaire - standards
Predictive Value of Tests
Psychiatric Status Rating Scales - standards
Psychometrics
Reproducibility of Results
ROC Curve
Sensitivity and Specificity
title The Validity and Reliability of Screening Measures for Depression and Anxiety Disorders in Inflammatory Bowel Disease
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T19%3A47%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Validity%20and%20Reliability%20of%20Screening%20Measures%20for%20Depression%20and%20Anxiety%20Disorders%20in%20Inflammatory%20Bowel%20Disease&rft.jtitle=Inflammatory%20bowel%20diseases&rft.au=Bernstein,%20Charles%20N&rft.aucorp=CIHR%20Team%20in%20Defining%20the%20Burden%20and%20Managing%20the%20Effects%20of%20Immune-mediated%20Inflammatory%20Disease&rft.date=2018-08-16&rft.volume=24&rft.issue=9&rft.spage=1867&rft.epage=1875&rft.pages=1867-1875&rft.issn=1078-0998&rft.eissn=1536-4844&rft_id=info:doi/10.1093/ibd/izy068&rft_dat=%3Cproquest_pubme%3E2027586563%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c408t-522e7596382f0e26dc05ef7e0e91ba2f6bfb50251e5b2a6b9fba8e8be68bafb3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2027586563&rft_id=info:pmid/29668911&rft_oup_id=10.1093/ibd/izy068&rfr_iscdi=true